Literature DB >> 23754344

Lack of association between IL-23R gene polymorphisms and systemic lupus erythematosus in a Chinese population.

Gui-Mei Chen1, Chen-Chen Feng, Qian-Ling Ye, Juan Wang, Han Cen, Rui Li, Hui Peng, Mo Zhou, Rui-Xue Leng, Yin-Guang Fan, Jin-Hui Tao, Hai-Feng Pan, Dong-Qing Ye.   

Abstract

OBJECTIVE: The aim to this study was to investigate the association between the single-nucleotide polymorphisms (SNPs) of interleukin (IL)-23 receptor gene and systemic lupus erythematosus (SLE) in a Chinese population.
METHODS: A case-control study was performed to investigate the associations of SNPs in IL-23R gene (rs10889677 and rs1884444) with susceptibility to SLE in 521 Chinese SLE patients and 527 normal controls. The chi-square test and unconditional Logistic regression were used to analysis by SPSS 10.1 software.
RESULTS: No significant differences were detected for the distribution of allele and genotype frequencies of these two SNPs between patients and controls as well as SLE patients with nephritis (LN) and those without nephritis.
CONCLUSION: The findings suggest that the polymorphisms of IL-23R gene might not contribute to the susceptibility of SLE in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23754344     DOI: 10.1007/s00011-013-0636-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  30 in total

1.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

2.  Decreased serum IL-22 levels in patients with systemic lupus erythematosus.

Authors:  Hai-Feng Pan; Xue-Fei Zhao; Hui Yuan; Wen-Hui Zhang; Xiang-Pei Li; Gui-Hong Wang; Guo-Cui Wu; Xiao-Wu Tang; Wen-Xian Li; Lian-Hong Li; Jin-Bao Feng; Chun-Song Hu; Dong-Qing Ye
Journal:  Clin Chim Acta       Date:  2008-11-17       Impact factor: 3.786

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses.

Authors:  Ritu Sarin; Xingxin Wu; Clara Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

5.  Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis.

Authors:  Yu Zhai; Ke Xu; Fen Huang; Hui Peng; Chen-Chen Feng; Kao-Kao Zhu; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

6.  Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series.

Authors:  Tugce Karaderi; David Harvey; Claire Farrar; Louise H Appleton; Millicent A Stone; Roger D Sturrock; Matthew A Brown; Paul Wordsworth; Jennifer J Pointon
Journal:  Rheumatology (Oxford)       Date:  2009-02-02       Impact factor: 7.580

Review 7.  Lupus in the developing world--is it any different?

Authors:  Mohammed Tikly; Sandra V Navarra
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-08       Impact factor: 4.098

8.  The association between interleukin-23 receptor gene polymorphisms and systemic lupus erythematosus.

Authors:  Yi Li; Wei-Bo Liang; Cui Li; Lin-Bo Gao; Bin Zhou; Yan-Yun Wang; Mei-Li Lv; Ya-Ping Song; Lin Zhang
Journal:  DNA Cell Biol       Date:  2010-02       Impact factor: 3.311

9.  Increased serum interleukin 17 in patients with systemic lupus erythematosus.

Authors:  Xue-Fei Zhao; Hai-Feng Pan; Hui Yuan; Wen-Hui Zhang; Xiang-Pei Li; Gui-Hong Wang; Guo-Cui Wu; Hong Su; Fa-Ming Pan; Wen-Xian Li; Lian-Hong Li; Guo-Ping Chen; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2009-04-04       Impact factor: 2.316

10.  The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.

Authors:  B Rueda; J Broen; O Torres; C Simeon; N Ortego-Centeno; M M V A P Schrijvenaars; M C Vonk; V Fonollosa; F H J van den Hoogen; M J H Coenen; J Sanchez-Román; M A Aguirre-Zamorano; R García-Portales; A Pros; M T Camps; M A Gonzalez-Gay; J Martin; T R D J Radstake
Journal:  Ann Rheum Dis       Date:  2008-08-19       Impact factor: 19.103

View more
  2 in total

1.  A functional microRNA binding site variant in IL-23R gene in systemic lupus erythematosus and rheumatoid arthritis: is there any correlation?

Authors:  Samira Alesaeidi; Saeed Esmaeili Dizghandi; Goli Siri; Meysam Mosallaei; Taiebe Kenarangi; Tahereh Ghorashi; Mohsen Soosanabadi
Journal:  Mol Biol Rep       Date:  2022-10-10       Impact factor: 2.742

2.  Functional polymorphisms in interleukin-23 receptor and susceptibility to coronary artery disease.

Authors:  Meiyan Zhang; Zhen-Rong Cai; Bili Zhang; Xinmeng Cai; Wei Li; Zhifu Guo; Lan Ma
Journal:  DNA Cell Biol       Date:  2014-12       Impact factor: 3.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.